Comparison of clinical outcome after first-line platinum-based chemotherapy in different types of KRAS mutated advanced non-small-cell lung cancer

W.W. Mellema, L. Masen-Poos, E.F. Smit, L.E.L. Hendriks, JG Aerts, A. Termeer, M.J. Goosens, H.J.M. Smit, M.M. van den Heuvel, A.J. van der Wekken, G.J.M. Herder, F.H. Krouwels, J.A. Stigt, B.E.E.M. van den Borne, T.J. Haitjema, A. Staal-Van Den Brekel, R.C. van Heemst, E. Pouwq, A.M.C. Dingemans

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)249-254
JournalLung Cancer
Volume90
Issue number2
DOIs
Publication statusPublished - 2015

Cite this

Mellema, W. W., Masen-Poos, L., Smit, E. F., Hendriks, L. E. L., Aerts, JG., Termeer, A., Goosens, M. J., Smit, H. J. M., van den Heuvel, M. M., van der Wekken, A. J., Herder, G. J. M., Krouwels, F. H., Stigt, J. A., van den Borne, B. E. E. M., Haitjema, T. J., Staal-Van Den Brekel, A., van Heemst, R. C., Pouwq, E., & Dingemans, A. M. C. (2015). Comparison of clinical outcome after first-line platinum-based chemotherapy in different types of KRAS mutated advanced non-small-cell lung cancer. Lung Cancer, 90(2), 249-254. https://doi.org/10.1016/j.lungcan.2015.09.012